Figure 5 | Scientific Reports

Figure 5

From: Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic aid

Figure 5

Effect of the immunomodulator over the plasma neurotransmitter concentration of puppies affected by CPE. (A) Norepinephrine: A significant increase was observed in the CT + I group on day 1 of evaluation with respect to the CT + V group. (B) Epinephrine: No significant differences were observed between groups. (C) Serotonin: A considerable decrease was found in CT + V as compared to CT + I on day 2. Kruskal–Wallis test and Dunn's post-hoc test were carried out. Each dot represents a puppy. Median ± 5–95% confidence interval. *P ≤ 0.05. CT conventional treatment, I immunomodulatory, V vehicle.

Back to article page